Skip to main content
Caplight Logo









Relevium Medical

Relevium Medical

Private
IrelandHealthcare & Life Scienceshttps://relevium-medical.com/

Last Round

Grant

Nov 27, 2024

Total Funding Raised

$21.25M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Relevium Medical is a biopharmaceutical company that develops novel hydrogel-based therapeutics for the treatment of chronic pain conditions, including knee osteoarthritis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

neurostimulationpain managementnon-invasivemedical devicehydrogel therapeuticschronic painneuromodulationdrug deliverypain techbiopharmamedtechosteoarthritis treatmentclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Relevium Medical Comparables

Compare Relevium Medical with similar companies based on industry and business-model similarity.

Relevium Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DyAnsys, Inc.
77%
BioWave Corporation
74%
Medtronic
66%

Relevium Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 27, 2024
Series AJun 17, 2024
AcceleratorAug 22, 2022
SeedMay 1, 2022
GrantJan 19, 2022
Grant
Apr 22, 2021

Relevium Medical Investors

Notable investors and investment history

Relevium Medical investors
InvestorRounds
European Innovation Council FundSeed, Grant
Taighde Éireann – Research IrelandGrant
Y CombinatorSeed, Accelerator
Enterprise IrelandAccelerator, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 48% MoM.

  • Nov 27, 2024

    Secured $5M in grant funding from Enterprise Ireland.

Relevium Medical Filings

Explore SEC and related filing metadata, where available.

Relevium Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Relevium Medical's valuation, stock price, and market status.

Is Relevium Medical a public or private company?

Relevium Medical is a private company.

What is the current stock price of Relevium Medical?

Relevium Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Relevium Medical worth (valuation)?

Valuation information for Relevium Medical is not publicly available.

Can I buy Relevium Medical stock?

Relevium Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Relevium Medical's last funding round?

Relevium Medical's most recent funding round was Grant on November 8, 2024.

Who are the main investors in Relevium Medical?

Key investors in Relevium Medical include European Innovation Council, Enterprise Ireland.

Will Relevium Medical IPO soon?

No public IPO plans have been announced for Relevium Medical.

How can I track Relevium Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Relevium Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIreland
Employee Range2
Year Founded2019
Last FundingNov 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?